Sonnet BioTherapeutics Holdings, Inc. - ROE

The ROE as of June 2026 (TTM) for Sonnet BioTherapeutics Holdings, Inc. (SONN) is -518.10%

According to Sonnet BioTherapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -518.10%. This represents a change of 287.93% compared to the average of -133.55% of the last 4 quarters.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Historical ROE (quarterly & annually)

How has SONN ROE performed in the past?

The mean historical ROE of Sonnet BioTherapeutics Holdings, Inc. over the last ten years is 991.72%. The current -518.10% ROE has changed -152.24% with respect to the historical average. Over the past ten years (40 quarters), SONN's ROE was at its highest in in the September 2023 quarter at 1.63%. The ROE was at its lowest in in the June 2020 quarter at -3101.22%.

Sonnet BioTherapeutics Holdings, Inc. (SONN) ROE by Quarter and Year

Discovering the peaks and valleys of Sonnet BioTherapeutics Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Average ROE

How has SONN ROE performed in the past?

The current ROE of Sonnet BioTherapeutics Holdings, Inc. (SONN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sonnet BioTherapeutics Holdings, Inc. (SONN) ROE vs. Peers

How is SONN’s ROE compared to its peers?

Sonnet BioTherapeutics Holdings, Inc.’s ROE is greater than Rallybio Corporation (-14.39%), greater than TAO Synergies Inc. (-120.29%), greater than Klotho Neurosciences, Inc. (-137.57%), greater than Exicure, Inc. (-179.41%), greater than Intensity Therapeutics, Inc. (-136.82%), less than Iterum Therapeutics plc (602.38%), greater than Boundless Bio, Inc. (-53.60%), less than Q32 Bio Inc. (230.68%), greater than Cadrenal Therapeutics, Inc. Common Stock (-411.02%), greater than iBio, Inc. (-53.86%),

Build a custom stock screener for Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonnet BioTherapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonnet BioTherapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.